Calvert Laboratories

Contact: Jeff Tippett 919.459.8662   Cary, NC–November 11, 2010–Calvert Research, LLC announced today that one of the Company’s therapeutic development programs (T1-1081) qualified to receive federal grant funding totaling approximately $245,000 under the Patient Protection and Affordable Care Act of 2010 (“The ACT”), which will be used to help advance T1-1081 toward an IND application […]

CARY, North Carolina (June 9, 2009). Calvert Research today announced the execution of a license agreement with Tulane University granting Calvert Research (through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology platform and novel compounds which have the potential to treat a debilitating eye disease […]